We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Philip Morris (PM) Stock is Down 4.7% in 3 Months
Read MoreHide Full Article
Investors seem to lay low when it comes to Philip Morris International Inc. (PM - Free Report) . The tobacco giant’s shares have declined 4.7% in the past three months compared to the industry’s decline of 2.4%. Moreover, the stock fell nearly 4.3% in yesterday’s trading session, on market speculations of a merger between Philip Morris and tobacco giant Altria (MO - Free Report) .
Well, matters have not been very rosy for Philip Morris, thanks to sluggish cigarette sales volumes. This has been exerting pressure on the company’s top line performance for a while. Let’s delve deeper and also discuss the company’s efforts to cushion the same.
Declining Cigarettes Sales
Philip Morris’s cigarette shipment volumes declined 2.1% in 2018. The metric declined almost 3.6% in the second quarter, while revenues from overall combustible products declined 7.1%. The decline in cigarette consumption is largely attributable to consumers growing awareness toward the harmful impacts of nicotine.
Moreover, several regulatory impositions on cigarette manufacturing and its marketing have acted as a deterrent. This includes mandatory use of precautionary labels and issuing self-critical advertisements. Moreover, the FDA is inclined to drastically reduce nicotine in cigarettes to minimally-addictive levels. The initiative was proposed in 2017 but was delayed due to ongoing research.
Other tobacco firms such as British American Tobacco (BTI - Free Report) and Vector Group (VGR - Free Report) are reeling under declining cigarette sales volumes.
Are RRPs a Safe Haven?
With radical investments for research and development in the reduced-risk products (RRPs) category, Philip Morris is pioneering the radical shift from harmful tobacco products to scientific and low-risk alternatives. In fact, the company’s IQOS, a smokeless cigarette, is among one of the leading RRPs in the industry. IQOS users at the end of second-quarter 2019 totaled more than 11 million, marking an important milestone. In fact, strong growth in IQOS boosted revenues in the RRPs unit, which increased almost 43.7% in the second quarter. Moreover, heated tobacco unit’s shipment volumes improved 37% in the said period
The company expects RRPs to continue aiding adult smokers to switch from traditional cigarettes to smoke-free options. It is therefore investing toward bolstering the unit through new product launches across different market regions. This along with higher cigarette pricing strategies is likely to remain as upsides for this Zacks Rank #3 (Hold) company.
Although the RRPs portfolio is expanding, they are yet to become significant enough to mitigate declines in the larger cigarette units. Also, things are seemingly unclear surrounding rumors regarding Philip Morris’s merger with Altria.
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Here's Why Philip Morris (PM) Stock is Down 4.7% in 3 Months
Investors seem to lay low when it comes to Philip Morris International Inc. (PM - Free Report) . The tobacco giant’s shares have declined 4.7% in the past three months compared to the industry’s decline of 2.4%. Moreover, the stock fell nearly 4.3% in yesterday’s trading session, on market speculations of a merger between Philip Morris and tobacco giant Altria (MO - Free Report) .
Well, matters have not been very rosy for Philip Morris, thanks to sluggish cigarette sales volumes. This has been exerting pressure on the company’s top line performance for a while. Let’s delve deeper and also discuss the company’s efforts to cushion the same.
Declining Cigarettes Sales
Philip Morris’s cigarette shipment volumes declined 2.1% in 2018. The metric declined almost 3.6% in the second quarter, while revenues from overall combustible products declined 7.1%. The decline in cigarette consumption is largely attributable to consumers growing awareness toward the harmful impacts of nicotine.
Moreover, several regulatory impositions on cigarette manufacturing and its marketing have acted as a deterrent. This includes mandatory use of precautionary labels and issuing self-critical advertisements. Moreover, the FDA is inclined to drastically reduce nicotine in cigarettes to minimally-addictive levels. The initiative was proposed in 2017 but was delayed due to ongoing research.
Other tobacco firms such as British American Tobacco (BTI - Free Report) and Vector Group (VGR - Free Report) are reeling under declining cigarette sales volumes.
Are RRPs a Safe Haven?
With radical investments for research and development in the reduced-risk products (RRPs) category, Philip Morris is pioneering the radical shift from harmful tobacco products to scientific and low-risk alternatives. In fact, the company’s IQOS, a smokeless cigarette, is among one of the leading RRPs in the industry. IQOS users at the end of second-quarter 2019 totaled more than 11 million, marking an important milestone. In fact, strong growth in IQOS boosted revenues in the RRPs unit, which increased almost 43.7% in the second quarter. Moreover, heated tobacco unit’s shipment volumes improved 37% in the said period
The company expects RRPs to continue aiding adult smokers to switch from traditional cigarettes to smoke-free options. It is therefore investing toward bolstering the unit through new product launches across different market regions. This along with higher cigarette pricing strategies is likely to remain as upsides for this Zacks Rank #3 (Hold) company.
Although the RRPs portfolio is expanding, they are yet to become significant enough to mitigate declines in the larger cigarette units. Also, things are seemingly unclear surrounding rumors regarding Philip Morris’s merger with Altria.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>